STOCK TITAN

Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Applied Molecular Transport Inc. (Nasdaq: AMTI) will have CEO Tahir Mahmood participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 11:00 a.m. ET. The event will be streamed live on AMT's website, with an archived replay available for 30 days post-event.

AMT is a clinical-stage biopharmaceutical company focused on developing novel oral biologic products to treat various diseases. Their technology leverages natural cellular pathways for transporting therapeutics across the intestinal barrier, aiming to enhance treatment efficacy.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 11:00 a.m. ET.

A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. An archived replay will be available for 30 days following the event.

About Applied Molecular Transport Inc.
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelial (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com.

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com


FAQ

When is the Jefferies Virtual Healthcare Conference for AMTI?

The Jefferies Virtual Healthcare Conference for Applied Molecular Transport Inc. (AMTI) will take place on June 4, 2021, at 11:00 a.m. ET.

Who will represent AMTI at the Jefferies Conference?

Tahir Mahmood, Ph.D., the CEO and co-founder of Applied Molecular Transport Inc., will represent the company.

How can I watch AMTI's presentation at the Jefferies Conference?

You can watch AMTI's presentation live on their website's Events page, with a replay available for 30 days after the event.

What does Applied Molecular Transport Inc. focus on?

Applied Molecular Transport Inc. focuses on developing novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.

What is the key technology used by AMTI?

AMTI utilizes a proprietary technology platform that exploits natural cellular trafficking pathways to transport therapeutics across the intestinal barrier.

Applied Molecular Transport Inc.

NASDAQ:AMTI

AMTI Rankings

AMTI Latest News

AMTI Stock Data

11.01M
33.72M
21.36%
37.28%
0.47%
Biotechnology
Healthcare
Link
United States
South San Francisco